Skip to main content

COVID-19 randomised trial protocols: rapid publication without barriers

Trials is implementing a new, simplified process for handling COVID-19 protocols that describe randomised trials that focus on COVID-19, or its direct health consequences. Read the Editorial, COVID-19 randomised trial protocols: rapid publication without barriers for more information. We will endeavour to get back to all inquiries within 24 hours.

Read the Editorial

Click here

Register your interest with BMC

Click here

Download the structured summary template

Click here

Call for papers: Impact of COVID-19 on clinical trials

Trials is inviting submission of manuscripts, long and short, including Letters and Commentaries detailing the enforced changes to trial design; trial management; recruitment; consent process; intervention delivery and follow up as a result of the COVID-19 pandemic. We also welcome submission of Updates to protocols previously published in Trials that describe changes made because of the COVID-19 pandemic.

COVID-19 trial protocols

Read our published COVID-19 trial protocols

COVID-19 preprints

Read our current COVID-19 submissions on In Review

Read the latest SARS-CoV-2 and COVID-19 research from Springer Nature

Springer Nature is committed to supporting the global response to emerging outbreaks by enabling fast and direct access to the latest available research, evidence and data.

Read More

† Contact eleanor.cox@biomedcentral.com and jonathan.collin@biomedcentral.com